Preoperative staging and treatment options in T1 rectal adenocarcinoma

Acta Oncologica

Volumn 48, Issue 3, 2009, Pages 328-342

  Baatrup, Gunnar ^a,b   Endreseth, Birger H ^c,d   Isaksen, Vidar ^e   Kjellmo, Se ^c   Tveit, Kjell Magne ^f,g   Nesbakken, Arild ^g  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL;

ACCURACY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL EXAMINATION; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ENDOSCOPIC SURGERY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; METHODOLOGY; MICROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLON TECHNIQUE; PATIENT SELECTION; PHYSICAL PERFORMANCE; POLYP; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECTUM CARCINOMA; RECTUM RESECTION; RECURRENT DISEASE; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TRANSANAL ENDOSCOPIC MICROSURGERY; TUMOR BIOPSY; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT; ADENOCARCINOMA; PATHOLOGY; RECTUM TUMOR;

ADENOCARCINOMA; HUMANS; NEOPLASM STAGING; RECTAL NEOPLASMS;

EID: 65349133618     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802657243     Document Type: Review

References (112)

1. Endreseth BH, Romundstad P, Myrvold HE, Bjerkeset T, Vibe A. on behalf of the Norwegian Rectal Cancer Group. Rectal cancer treatment in the older population. Colorectal Dis 2006;/8:/471-9.
2. Pa°hlman L, Bohe M, Cedermark B, Dahlberg, M, Lindmark G, Sjödahl R, et al. The Swedish rectal cancer registy. Br J Surg 2007;/94:/1285-92.
3. Baatrup G, Breum B, Qvist N, Elbrønd H, Møller P, Hesselfeldt P. Transanal endoscopic microsurgery in 143 consecutive patients with rectal adenocarcinoma. Results from a Danish multicenter study. Colorectal Dis. Pubmed E-Pub ahead of print PMID 18573118.
4. Baatrup G, Elbrønd H, Hesselfeldt P, Wille-Jørgensen P, Møller P, Breum B, et al. Rectal adenocarcinoma and transanal endoscopic microsurgery. Diagnostic challenges, indications and short-term results in 142 consecutive patients. Int J Colorect Dis 2007;/22:/1347-52.
5. World Health Organization Classification of Tumours- Pathology & genetics- Tumours of the digestive system, 2000.
6. Qizilbash AH. Pathological studies in colorectal cancer: A guide to the surgical pathology examination of colorectal specimens and review of features of prognostic significance. Pathol Annu 1982;/17:/1-46.
7. Fenoglio-Preiser CM, Noffsinger AE, Lantz PE. Gastrointestinal pathology- an atlas and text, 3rd ed; 2008.
8. Denoix PF. French Ministry of Public Health National Institute of Hygiene Monograph No. 4, Paris, 1954.
9. TNM Classification of malignant tumours. UICC. 6th ed. Wiley-Liss Publication: 2002.
10. TNM-Atlas- Illustrated guide to the TNM/pTNM classi-fication of malignant tumours. 5th ed. UICC. Springer Verlag; 2005.
11. Sternberg SS. Histopathology for pathologists, 2nd edn. Lippincott; 1997.
12. Lee S, Bang S, Song K, Lee I. Differential expression in normal-adenoma-carcinoma sequence suggests complex carinogenesis in colon. Oncol Report 2006;/16:/747-54.
13. Nivatvongs S. Surgical management of malignant colorectal polyps. Surg Clin Am 2002;/82:/959-66.
14. Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas; implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985;/89:/328-36.
15. Kikuchi R, Takano M, Takagi K, Fujimoto N, Nozaki R, Fujiyoshi T, et al. Management of early invasive colorectal cancer. Risk of recurrence and clinical guidelines. Dis Colon Rectum 1995;/38:/1286-95.
16. Tytherleigh MG,Warren BF, Mortensen NJMcC. Management of early rectal cancer. Br J Surg 2008;/95:/409-23.
17. Nakamura T, Mitomi H, Kanazawa H, Ohkura Y, Watanabe M. Tumor budding as an index to identify high-risk patients with Stage II colon cancer. Dis Colon Rectum 2008;/51:/568-72.
18. Jass JR, O'Brien MJ, Riddell RH, Snover DC. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Virchows Arch 2008;/450:/1-13.
19. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour "budding" as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;/40:/ 127-32.
20. Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004;/ 127:/385-94.
21. Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Silverman JF. Lymphatic microvessel density as prognostic marker in colorectal cancer. Modern Pathol 2006;/19:/ 1317-23.
22. Derwinger K, Carlsson G, Gustavsson B. A study of lymph node ratio as a prognostic marker in colon cancer. EJSO 2007;1-5.
23. Szynglarewicz B, Matkowski R, Suder E, Sydor D, Forgacz J, Pudelko M, et al. Predictive value of lymphocytic infiltration and character of invasive margin following total mesorectal excision with sphincter preservation for the high-risk carcinoma of the rectum. Adv Med Sci 2007;/52:/ 160-3.
24. Goldstein NS. Recent pathology related advances in colorectal adenocarcinomas. EJSO 2001;/27:/446-50.
25. Wang Z, Zhou Z-G,Wang C, Zheng XL,Wang R, Li FY, et al. Regional micrometastasis of low rectal cancer in mesorectum: A study utilizing HE stain on whole-mount section and ISH analyses on tissue microarray. Cancer Invest 2006;/24:/374-81.
26. Hara M, Hirai T, Nakanishi H, Kanemitsu Y, Komori K, Tatematsu M, et al. Isolated tumor cell in lateral lymph node has no influences on the prognosis of rectal cancer patients. Int J Colorectal Dis 2007;/22:/911-7.
27. Prabhudesai A, Arif S, Finlayson CT, Kumar D. Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer. Dis Colon Rectum 2003;/46:/ 1531-7.
28. Keats AS. The ASA classification of physical status- a recapitulation. Anesthesiology 1978;/49:/233-6.
29. Valenti V, Hernandez-Lizoian JL, Baixauli J, Pastor C, Martinez-Regueira F, Beunza JJ, et al. Analysis of POSSUM score and postoperative morbidity in patients with rectal cancer undergoing surgery. Langenbecks Arch Surg 2008; PMID 18320211 (Epub ahead of print).
30. Tekkis PP, Prytherch DR, Kocher HM, Senepati A, Poloniecki JD, Stamatakis JD, et al. Develpoment of a dedicated risk- adjustment scoring system for colorectal surgery (colorectal POSSUM). Br J Surg 2004;/9:/1179-82.
31. Vather R, Zagar-Shoshtari K, Adegbola S, Hill AG. Comparison of the possum, P-POSSUM and Cr-POSSUM scoring systems as predictors of postoperative mortality in patients undergoing major colorectal surgery. ANZ J Surg 2006;/76:/812-6.
32. Gschwantler M, Kriwantek S, Langner E, Gö ritzen B, Schrutka-Kö lbl C, Brownstone E, et al. High-grade dysplasia and invasive carcinoma in colorectal adenomas: A multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol 2002;/14:/ 183-8.
33. Nusko G, Mansmann U, Partzcsch U, Altendorf-Hofmann A, Groitl H, Witteking C, et al. Invasive carcinoma in colorectal adenomas: Multivariate analysis of patient and adenoma characteristics. Endoscopy 1997;/29:/626-31. (Pubitemid 27472603)
34. Kudo S, Kashida H, Nakajima T, Tamura S, Nakajo K. Endoscopic diagnosis and treatment of early colorectal cancer. World J Surg 1997;/21:/694-701.
35. Kudo S, Rubio CA, Teixeira CR, Kashida H, Kogure E. Pit pattern in colorectal neoplasia: Endoscopic magnifying view. Endoscopy 2001;/33:/367-73.
36. Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging -a meta-analysis. Radiology 2004;/232:/773-83.
37. Doornebosch PG, Bronkhorst PJ, Hop WC, Bode WA, Sing Ak, de Graaf EJ. The role of endorectal ultrasound in therapeutic decision-making for local vs. transabdominal resection of rectal tumors. Dis Colon Rectum 2008;/51:/ 38-42.
38. Marusch F, Koch A, Schmidt U, Zippel R, Kuhn R, Wolff S, et al. Routine use of transrectal ultrasound in rectal carcinoma: Results of a prospective multicenter study. Endoscopy 2002;/34:/385-90.
39. Ptok H, Marusch F, Meyer F, Wendling P, Wenisch HJ, Sendt W, et al. Feasibility and accuracy of TRUS in the pre-treatment staging for rectal carcinoma in general practice. Eur J Surg Oncol 2006;/32:/420-5.
40. Garcia-Aguilar J, Pollack J, Lee SH, Hernandez de Anda E, Mellgren A, Wong WD, et al. Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum 2002;/45:/10-5.
41. Starck M, Bohe M, Simanaitis M, Valentin L. Rectal endosonography can distinguish benign rectal lesions from invasive early rectal cancers. Colorectal Dis 2003;/5:/ 246-50.
42. Knaebel HP, Koch M, Feise T, Benner A, Kienle P. Diagnostics of rectal cancer: Endorectal ultrasound. Recent Results Cancer Res 2005;/165:/46-57.
43. Akasu T, Sugihara K, Moriya Y, Fujita S. Limitations and pitfalls of transrectal ultrasonography for staging of rectal cancer. Dis Colon Rectum 1997;/40(Suppl):/10-5.
44. Dworak O. Morphology of lymph nodes in the resected rectum of patients with rectal carcinoma. Pathol Res Pract 1991;/187:/1020-4.
45. Kotanagi H, Fukuoka T, Shibata Y, Yoshioka T, Aizawa O, Saito Y, et al. The size of regional lymph nodes does not correlate with the presence or absence of metastasis in lymph nodes in rectal cancer. J Surg Oncol 1993;/54:/252-4.
46. Giovannini M, Hookey LC, Bories E, Pesenti C, Monges G, Delpero JR. Endoscopic ultrasound elastrographyy: The first step towards virtual biopsy? Preliminary results in 49 patients. Endoscopy 2006;/38:/344-8.
47. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003;/90:/355-64.
48. Bipat S, Glas AS, Slors FJM, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal us, CT, and MR imaging- meta-analysis. Radiology 2004;/232:/773-83.
49. Gualdi GF, Casciani E, Guadalaxara A, d'Orta C, Polettini E, Pappalardo G. Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: Comparison with histologic findings. Dis Colon Rectum 2000;/43:/338-45.
50. Maldjian C, Smith R, Kilger A, Schnall M, Ginsberg G, Kochman M. Endorectal surface coil MR imaging as a staging technique fort rectal carcinoma: A comparison study to rectal endosonography. Abdom Imaging 2000;/ 25:/75-80.
51. Kim CKK, Kim SH, Chun HK, Lee WY, Yun SH, Song SY, et al. Preoperative staging of rectal cancer: Accuracy of 3-Tesla magnetic resonance imaging. Eur Radiol 2006;/16:/ 972-80.
52. Chun HK, Choi D, Kim MJ, Lee J, Yun SH, et al. Preoperative staging of rectal cancer: Comparison of 3-T high-field MRI and endorectal sonography. AJR 2006;/187:/ 1557-62.
53. Rao S-X, Zeng M-S, Chen C-Z, Li RC, Zhang SJ, Xu JM. The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur Radiol 2008;/65:/299-303.
54. Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of highspatial-resolution MR imaging with histopathologic comparison. Radiology 2003;/227:/371-7.
55. Koh DM, Brown G, Temple L, Raja A, Toomy P, Bett N, et al. Rectal cancer: Mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings- initial observations. Radiology 2004;/231:/91-9.
56. LahayeMJ, Engelen SME, Kessel AGH, de Bruïne AP, von Meyenfeldt MF, van Engelshoven JM, et al. USPIOenhanced MR imaging for nodal staging in patients with primary rectal cancer: Predictive criteria. Radiology 2008;/ 246:/804-11.
57. Kwok H, Bissett IP, Hill GL. Preoperative staging of rectal cancer. Int J Colorectal Dis 2000;/15:/9-20.
58. Beets-Tan RGH, Beets GL. Rectal cancer: Review with emphasis on MR imaging. Radiology 2004;/232:/335-46.
59. Rifkin MD, Ehrlich SM. Marks G. Staging of rectal carcinoma: Prospective comparison of endorectal US and CT. Radiology 1989;/170:/319-22. (Pubitemid 19035646)
60. Sinha R, Verma R, Rajesh A, Richards CJ. Diagnostic value of multidetector row CT in rectal cancer staging: Comparison of multiplanar and axial images with histopathology. Clin Radiol 2006;/61:/924-31.
61. Vliegen R, Dresen R, Beets Geerard, Daniels-Gooszen A, Kessles A, van Engelshoven J, et al. The accuracy of Multidetector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancer. Abdom Imaging 2008;/33:/604-10.
62. Galandiuk S, Fazio VW, Jagelman DG, Lavery IC, Weakley FA, Petras RE, et al. Villous and tubulovillous adenomas of the colon and rectum. A retrospective review, 1964-1985. Am J Surg 1987;/153:/41-7.
63. Taylor EW, Thomson H, Oates GD, Dorricott NJ, Alexander-Williams J, Keighley MR. Limitations of biopsy in preoperative assessment of villous papilloma. Dis Colon Rectum 1981;/24:/259-62.
64. Mousavi J, Lunde OC, Nesbakken A. Preoperative staging of in-situ carcinoma and early rectal cancer. Abstract 152, Norwegian Surgical Society. Oslo: 2006.
65. Kneist W, Terzic A, Burghardt J, Heintz A, Junginger T. Selection of patients with rectal tumors for local excision based on preoperative diagnosis. Results of a consecutive evaluation study of 552 patients. Chirurg 2004;/75:/168-75.
66. Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G. Biopsy of colorectal polyps is not adequate for grading of neoplasia. Endoscopy 2005;/37:/1193-7.
67. Nesbakken A, Løvig T, Lunde OC. Staging of rectal carcinoma with transrectal ultrasonography. Scand J Surg 2003;/92:/125-9.
68. Mousav IJ, Lunde OC, Nesbakken A. Premalignant polyps in the rectum treated with Transanal Endoscopic Microsurgical (TEM-) resection. Abstract 150, Norwegian Surgical Society. Oslo: 2006.
69. Endreseth BH, Myrvold HE, Romundstad P, Hestvik UE, Bjerkeset T, Wibe A. On behalf of the Norwegian Rectal Cancer Group. Transanal excision versus major surgery for T1 rectal cancer. Dis Colon Rectum 2005;/48:/1380-8.
70. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancer of the gastrointestinal tract by using non-invasive imaging methods (US, CT, MR Imaging, PET): A meta-analysis. Radiology 2002;/ 224:/ 748-56.
71. Kjellmo A, Drolsum A. Diagnosis and staging of colorectal cancer. Tidsskr Nor Laegeforen 2007;/127:/2824-8.
72. Toricelli P. Rectal cancer staging. Surg Oncol 2007;/16:/ 49-50.
73. Stergiou N, Riphaus A, Lange P, Menke D, Köckerling F, Wehrmann T. Endoscopic snare resection of large colonic polyps: How far can we go? Int J Colorectal Dis 2003;/18:/ 131-5.
74. Schafer HH, Vivaldi C, Holscher AH. Local excision with transanal endoscopic microsurgery (TEM) after endoscopic R1/R2-polypectomy of pT1 "low-risk" carcinomas of the rectum. Z Gastroenterol 2006;/44:/647-50.
75. Welch JP, Welch CE. Villous adenomas of the colorectum. Am J Surg 1976;/131:/185-91.
76. Winde G, Nottberg H, Keller R, Schmid KW, Bünte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum 1996;/39:/969-76.
77. Heintz A, Morschel M, Junginger T. Comparison of results after transanal endoscopic microsurgery and radical resection for T1 carcinoma of the rectum. Surg Endosc 1998;/12:/ 1145-8.
78. Langer C, Liersch T, Suss M, Siemer A, Markus P, Ghadimi BM, et al. Surgical cure for early rectal carcinoma and large adenoma: Transanal endoscopic microsurgery (using ultrasound or electrosurgery). Int J Colorectal Dis 2003;/18:/222-9.
79. Lee W, Lee D, Choi S, Chun H. Transanal endoscopic microsurgery and radical surgery for T1 and T2 rectal cancer. Surg Endosc 2003;/17:/1283-7.
80. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002;/45:/200-6.
81. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;/ 246:/693-701.
82. Moriya Y. Function preservation in rectal cancer surgery. Int J Clin Oncol 2006;/11:/339-43.
83. Borschitz T, Heintz A, Junginger T. The influence of histopathological criteria on the long-term prognosis of locally excised pT1 rectal carcinomas: Results of local excision (Transanal Endoscopic Microsurgery) and immediate reoperation. Dis Colon Rectum 2006;/49:/ 1492-506.
84. Lee WY, Lee WS, Yun SH, Shin SH, Chun HK. Decision for salvage treatment after transanal endoscopic microsurgery. Surg Endosc 2007;/21:/975-9.
85. Baron PL, Enker WE, Zakowski MF, Urmacher C. Immediate vs. salvage resection after local treatment for early rectal cancer. Dis Colon Rectum 1995;/38:/177-81.
86. Friel CM, Cromwell JW, Marra C, Madoff RD, Rothenberger DA, Garcia-Aguílar J. Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum 2002;/45:/875-9.
87. Weiser MR, Landmann RG, Wong WD, Shia SH, Guillem JG, Temple LK, et al. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 2005;/ 48:/1169-75.
88. Bouvet M, Milas M, Giacco GG, Cleary KR, Janjan NA, Skibber JM. Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol 1999;/6:/26-32.
89. Wagman RT, Minsky BD. Conservative management of rectal cancer with local excision and adjuvant therapy. Oncology (Williston Park) 2001;/15:/513-28.
90. Le Voyer TE, Hoffmann JP, Cooper H, Ross E, Sigurdson E, Eisenberg B. Local excision and chemoradiaton for low rectal T1 and T2 cancers is an effective treatment. Am Surg 1999;/65:/625-31.
91. Benson R, Wong CS, Cummings BJ, Brierley J, Catton P, Ringash J, et al. Local excision and postoperative radiotherapy for distal rectal cancer. Int J Radiat Oncol Biol Phys 2001;/50:/1309-16.
92. Aitken RJ. Definition of local recurrence after surgery for rectal carcinoma. Br J Surg 1995;/82:/1285.
93. Bretagnol F, Merrie A, George B, Warren BF, Mortensen NJ. Local excision of rectal tumours by transanal endoscopic microsurgery. Br J Surg 2007;/94:/627-33.
94. Ganai S, Kanumuri P, Rau RS, Alexander AI. Local recurrence after transanal endoscopic microsurgery for rectal polyps and early cancers. Ann Surg Oncol 2006;/13:/ 547-56.
95. Floyd ND, Saclarides TJ. Transanal endoscopic microsurgical resection of pT1 rectal tumors. Dis Colon Rectum 2006;/49:/164-8.
96. Stipa F, Burza A, Lucandri G, FerriM, Pigazzi A, Ziparo V, et al. Outcomes for early rectal cancer managed with transanal endoscopic microsurgery: A 5-year follow-up study. Surg Endosc 2006;/20:/541-5.
97. Palma P, Freudenberg S, Samel S, Post S. Transanal endoscopic microsurgery: Indications and results after 100 cases. Colorectal Dis 2004;/6:/350-5.
98. Mentges B, Buess G, Effinger G, Manncke K, Becker HD. Indications and results of local treatment of rectal cancer. Br J Surg 1997;/84:/348-51.
99. Bentrem DJ, Okabe S,Wong WD, Guillem JG,Weiser MR, Temple LK, et al. T1 adenocarcinoma of the rectum: Transanal excision or radical surgery? Ann Surg 2005;/242:/ 472-7.
100. Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum 2000;/43:/1064-71.
101. Tveit KM, Guldvog I, Hagen S, Trondsen E, Harbitz T, Nygaard K, et al. Randomized controlled trial of postoperative radiotherapy and short-term-scheduled 5-fluorouracil against surgery alone in the treatment group of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 1997;/84:/1130-5.
102. Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin-Sta°hl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 2003;/42:/476-92. (Pubitemid 37193839)
103. Mohiuddin M, Hayne M, Regine WF, Hanna N, Hagihara PF, McGrath P, et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000;/48:/1075-80.
104. Habr-Gama A. Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy. Colorectal Dis 2006;/8(Suppl 3):/21-4.
105. Glynne-Jones R, Wallace M, Livingstone JIL, Meyrick-Thomas J. Complete clinical response after preoperative chemoradiation in rectal cancer: Is a ''wait and see'' policy justified? Dis Colon Rectum 2008;/51:/10-9.
106. O'Neill BDP, Brown G, Heald RJ, Cunningham D, Tait DM. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 2007;/8:/ 625-33. (Pubitemid 47008889)
107. You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified? A nationwide cohort study from the national cancer database. Ann Surg 2007;/245:/726-33.
108. Min BS, Kim NK, Ko YT, Lee KY, Baek SH, Cho CH, et al. Long-term oncologic results of patients with distal rectal cancer treated by local excision with or without adjuvant treatment. Int J Colorectal Dis 2007;/22:/1325-30.
109. Russel AH, Harris J, Rosenberg PJ, Sause WT, Fisher BJ, Hoffman JP, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: Long-term results of radiation therapy. J Radiat Oncol Biol Phys 2000;/46:/313-22.
110. Stamos MJ, Murrell Z. Management of early rectal T1 and T2 cancers. Clin Cancer Res 2007;/13(22 Suppl):/6885-9.
111. Gerard JP, Romestaing P, Chapet O. Radiotherapy alone in the curative treatment of rectal carcinoma. Lancet Oncol 2003;/3:/158-66. (Pubitemid 36322306)
112. Winslow ER, Kodner IJ, Mutch MG. Outcome of salvage abdominoperineal resection after failed endocavitary radiation in patients with rectal cancer. Dis Colon Rectum 2004;/ 47:/2039-46.